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MAMMARY tumour growth in mice was shown to be associated with changes
in tissue, serum and urine proteins (Pikovski and Witz, 1961a, b). It was observed
that there was an increase in three protein fractions of sera from mice bearing
mammary carcinomas. These proteins were found to be present in a higher
concentration in the tumour than in some normal tissues of normal and tumour-
bearing mice. In addition, at least two of these proteins were detected in the
urine oftumour-bearing but not ofnormal mice. In order to identify the proteins
involved, an immunochemical study of mammary tumour extracts, and of sera
and urine of normal and tumour-bearing mice was undertaken.
The first part of the present study indicates the changes occurring in serum
proteins of mice bearing tumours and defines some proteins present in extracts
of these tumours.
The second part deals with partial purification and identification of two
proteins which are conspicuous constituents of serum and tumour extracts.
In the third part, an immunoelectrophoretic analysis of normal and cancerous
mouse urine was carried out.
MATERIALS AND METHODS
Mice and tumours
The RIII mice used in this study, and the strain of transplantable mammary
carcinoma (MMCIA) were described previously (Pikovski and Witz, 1961b).
Tumour extracts
Tumours, 12-15 days after transplantation, were used for extraction. The
tumours were extracted with phosphate buffer (M/15, pH 7 4). Two such extracts
were prepared, one designated TL from lyophilized tumours as described pre-
viously (Pikovski and Witz, 1961b). The second (designated TF), was prepared
from fresh tumours, which have been perfused in situ with Earl's saline as modified
by Grabar, Seligmann and Bernard (1955). After the tumours were excised,
they were rinsed in the perfusion liquid. Selected non-haemorrhagic and non-
necrotic parts of tumours were then cut up, and a small quantity of buffer was
added. It was then homogenized for 5 minutes with a MSE homogeniser, using
the 10 ml. "Vortex Beaker ", while the holder housing the beaker was filled
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with ice. Buffer was then added to give a final volume of 4 ml. per g. tumour
tissue. The mash was left overnight at 40 C. The following day, it was centri-
fuged 3 times at high speed (10,000 X g), for 20 minutes each time. (Usually
there still was a sediment after the second centrifugation, and the third was
carried out to completely remove all sedimentable material. The third centri-
fugation could however be omitted if no sediment were obtained after the second
centrifugation). The clear supernatant was distributed in ampoules and kept
frozen. For electrophoretic and immunoelectrophoretic studies of tumour
extracts, a sample containing a constant amount of protein was applied to the
plates (i.e. 500-600 micrograms).
Mouse sera
Blood of normal and tumour-bearing mice was obtained by cardial puncture
or puncture of the ophthalmic venous plexus with a capillary pipette. Tumour-
bearing mice were bled 10-14 days after transplantation. Serum was separated
from coagulated blood by centrifugation. Sera from 8-15 mice were pooled
and stored frozen until used.
Mouse urine
Urine was obtained from male mice while stimulating them in the chest
region with a single electric impulse (100 v) of short duration (<1 second);
this treatment did not appear to cause any pain to the animals. Urine from
tumour-bearing mice was collected 9-15 days after tumour transplantation.
The urine was pooled, dialysed for 12-16 hours against phosphate-buffered saline
(pH 7.4) and concentrated 4-5 times its original volume by perventilation.
Volumes containing 500-600,tg. ofprotein were applied to agar plates for immuno-
chemical examination.
Antisera
Antisera were produced in rabbits. Antisera to MMCIA and to urine of
tumour-bearing mice were prepared as described previously (Pikovski and Witz,
1961b). Antisera to normal sera and urine of mice were prepared according to
the immunization schedule described by de Vaux St. Cyr and Hermann (1963).
These two immunization schedules were compared by immunizing rabbits with
the same antigens (mouse sera and tumour extracts), in both ways, and then by
analysing the precipitation patterns given by the resulting antisera. No signi-
ficant differences in the patterns of the two antisera obtained by the two ways
of immunization were detected. Also used in this study were antisera to the
following fractions:
(1) Mouse gamma globulin and transferrin obtained by DEAE cellulose
chromatography of mouse serum (Talal, Hermann, de Vaux St. Cyr and Grabar,
1963).
(2) Mouse transferrin and beta 2 III globulin. The preparation ofthis fraction
is described further on in the present paper.
Agar gel electrophoresis
Agar gel electrophoresis was performed in 1 per cent agar gel, employing a
barbital buffer pH 82. at a concentration of 0*025 M in the agar and 0*05 M in
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the reservoirs. The current was 6 v/cm. The plates measured 4-4 cm. by
10*7 cm. The duration of electrophoresis was 75 minutes.
Immunochemical techniques
Immunoelectrophoresis was performed according to Grabar and Williams
(1953, 1955). The identification of the precipitation lines given by mouse serum
constituents in the immunoelectrophoretic analyses was according to the nomen-
clature used by Heremans et al. (1959). In fresh sera the beta 3 I globulin shows
a precipitation line with a single curve. If the serum is older than 24 hours
changes occur, and this line becomes double curved. The other precipitation
lines seem to remain unchanged. Proteins were stained with amido black after
agar gel electrophoresis and with Ponceau S after immunoelectrophoresis, lipo-
proteins with sudan black and the esterases are visualized with beta-naphthyl-
acetate and indoxylacetate as substrates with the methods indicated by Uriel
(1960, 1961) and used previously (Talal, Hermann, de Vaux St. Cyr, 1962; Talal,
Hermann, de Vaux St. Cyr and Grabar, 1963).
Haemoglobin binding was visualized with the method of Hirschfeld (1959),
using human haemoglobin.
Antisera were absorbed by mixing 17-27 mg. ofabsorbing antigen with 1-0 ml.
of antiserum. The mixture was incubated at 370 C. for 1 hour and then left at
40 C. over night. The following day it was centrifuged. Completion of absorp-
tion was checked by a negative reaction between absorbed antiserum and
absorbing antigens.
Protein estimation
Proteins were determined with the Biuret reagent (Kabat and Mayer, 1961),
and their concentration measured spectrophotometrically at 555 mi/. Human
serum albumin was used as a standard.
Abbreviations
Abbreviations used in this study were as follows:
I.E.A.-Immunoelectrophoretic analysis.
NMS-Normal mouse serum.
TMS-Serum from tumour-bearing mice.
TL-Extract from lyophilized tumour.
TF-Extract from fresh tumour.
NMU-Normal mouse urine.
TMU-Urine from tumour-bearing mice.
RESULTS
1. Tumour Extracts and Sera of Normal and Tumour-bearing Mice
Agar gel electrophoresis of normal mouse serum and serum from tumour-
bearing animals and tumour extracts was carried out parallel with immuno-
electrophoretic analysis ofthese materials. The results obtained were as follows:
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Agar gel electrophoresis
(1) Serum from tumour-bearing mice compared with NMS showed an increase
in alpha globulins and a decrease in gamma globulins (Fig. IA) and an increase
in alpha lipoproteins (Fig. iB). No difference in the esterase activity of the
various protein fractions of the two types of sera was detected (Fig. 1c). The
magnitude of these differences requires further work with other techniques and
quantitative evaluation of the protein fractions.
(2) The tumour extracts showed the presence of at least three protein fractions
migrating respectively in the region of serum albumin, alpha globulins and beta
globulins (Fig. ID). Lipoproteins were demonstrable with a migration somewhat
slower than that found in normal serum (Fig. IE). Analysis for esterases (Fig.
IF), showed the presence of esterase activity corresponding to Rho lipoprotein-
csterase and the alpha 2 esterases of serum. Of particular interest however, is
the presence of an esterase with an electrophoretic migration in the beta-gamma
globulin region. An esterase of this type does not exist in serum. In all three
zones a hydrolysis of beta naphtyl-acetate and of indoxyl-acetate occurred.
No hydrolysis of acetyl-thiocholine or of butyryl-thiocholine was observed in
any of the zones.
Imrnmunoelectrophoretic analyses (I.E.A.)
Sera from normal and tumour-bearing mice were compared by I.E.A. Antisera
to normal mouse serum (NMS) and to the mouse tumour extracts were used in
this study. The antibody content of the two antisera differed with respect to
certain specific proteins. The anti-NMS, for example, appeared to have a higher
titre of antibodies against the beta 3 I globulin and a lower titre against the
beta 2 I and the beta 2 III globulins than the anti-tumour serum. Comparisons
between antigens was therefore made with the antiserum showing the highest
titre for the protein to be examined. Criteria of increased concentration were
an increase in density and length of a given precipitation line (Burtin, 1960).
The main difference between the proteins of NMS and TMS is found in an
increased concentration of beta 2 I globulin and beta 2 III globulin which occur
in the TMS (see Fig. 2A). This difference is much more obvious when the two
sera are diluted. Fig. 2B shows the precipitation pattern obtained with NMS
and TMS diluted 1: 5. The diluted NMS almost did not produce the beta 2 III
globulin arc (only a small fragment of the line is still visible), while the diluted
TMS produced a strong line. The augmentation of the beta 2 I globulin in the
TMS is less obvious, but nevertheless the diluted TMS produced a denser and
longer beta 2 I globulin band which was also closer to the antibody trough than
that produced by diluted NMS. All these facts indicate its higher concentration
in the serum of tumour-bearing mice. In addition there is an indication of an
increase of beta 3 I globulin.
I.E.A. oftumour extracts both from lyophilized (TL 1 and 2) and fresh tumour
(TF) were also carried out against the two types of antisera mentioned above.
The precipitation lines were more pronounced with antisera to tumour than with
those to NMS (Fig. 3A). The beta 2 I and the beta 2 III lines were very con-
spicuous. The appearance of several lines, not produced by mouse serum, could
be revealed by some immune sera to the tumour extracts. This was proved
when analyses were carried out with these antisera absorbed with NMS. Three
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lines were evident when the absorbed sera reacted with the tumour extracts
(Fig. 3B), revealing thus the presence in the tumour of non-serum antigens.
I.E.A. revealed that these antigens had electrophoretic mobilities similar to beta
and gamma globulins of serum.
The perfused fresh tumour extracts (TF) contained less of serum proteins
than did the non-perfused lyophilized extracts (TL). This is possibly due to
better removal of serum proteins in the first. The tissular non-serum proteins
demonstrated in tumour extracts, could be better revealed in the lyophilized
preparation.
It should be noted also that, although beta 3 I was an obvious constituent
in TMS, it could not be demonstrated in tumour extracts. The area of the alpha
globulins was too smeared (in relation to the separation normally obtained with
mouse serum) to permit analysis.
II. Partial Purification of the Beta 2 I and Beta 2 III Proteins
Because ofthe increased concentrations ofthe beta 2 I and beta 2 III globulins
both in sera and in tumours, attempts were made to separate out these two
protein fractions.
Since it has been suggested by Clausen and Heremans (1960) that the mouse
beta 2 III is analogous to human beta 2 A, the fractionation procedure of Here-
mans, Heremans and Schultze (1959) for isolation of this protein was attempted
on mouse sera and tumour fluids found in solid mammary tumours. The fluid
is composed of serous, sometimes haemorrhagic exudate and interstitial fluid.
It was found that both beta 2 globulins and other proteins (including albumin)
were soluble in 0-1 M zinc sulphate. In order to eliminate these additional
proteins, a preliminary separation with rivanol (diamino ethoxyacridine lactate)
was carried out. The final fractionation procedure is shown in Fig. 4. The
fraction thus obtained contains two proteins as shown in Fig. 5A; they cor-
respond in position to beta 2 I and beta 2 III found in both tumour extracts
and in serum of MMCIA-bearing mice.
When antisera against this beta 2 globulin fraction were prepared, only two
precipitation lines were obtained with whole mouse serum (Fig. 5B). This
would indicate that the fractionation procedure resulted in only 2 proteins of
different antigenic makeup.
Clausen and Heremans (1960) observed a cross-reaction between human
transferrin and mouse beta 2 I globulin and thus concluded that this protein
is the mouse transferrin. Definite proof for this assumption was presented by
Clausen et al. (1960) using radioactive iron incorporation, and by Hermann
and Bao-Dinh (1962, personal communication) by coloration of the iron bound
to the transferrin, according to Uriel's method (unpublished data).
The haemoglobin binding capacity of mouse beta 2 III globulin was originally
established by Velez and Hermann (1962, personal communication). These
findings are confirmed in the present study. Haemoglobin was added to whole
tumour extract and to the final globulin fraction, and immunoelectrophoresis
carried out. The plate was photographed and then treated with benzidine in
order to visualize the protein-bound haemoglobin by its peroxidase activity.
The results of this test are shown in Fig. 6, which is a photomontage showing on
the outer strips the pattern obtained after the immunoelectrophoretic procedure,
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and on the inner strips the benzidine-stained precipitation bands of the same
plate. Aside from the spot corresponding to free haemoglobin, it can be seen
that the beta 2 IIIlines of the fraction and of the tumour extract were stained,
indicating that the protein has bound haemoglobin.
The identification of the second beta 2 globulin is shown in Fig. 7. A specific
antiserum to mouse transferrin and gamma globulin was used in the I.E.A.
The specificity of the antiserum is shown in the pattern obtained with NMS
in which only two lines are evident (sometimes a third line-produced by beta
EXPLANATION OF PLATES
FIG.1. Agar gel electrophoresis of mouse sera and tumour extracts.
A-c. Mouse sera (left of each pair normal mouse serum (NMS)), (right of each pair-
serum of tumour-bearing mice (TMS)).
D-F. Tumour extracts.
A, D are stained to visualize proteins.
B, E are stained to show lipoproteins.
C, F are stained to show esterase activity.
Fie. 2. Immunoelectrophoretic analysis of mouse sera. NMS-normal mouse serum.
TMS-serum from tumour-bearing mice. The arrow No.1 indicates the precipitation arc
given by beta 2I globulin and No. III indicates beta 2 III globulin.
A. Note that (1) TMS, when reacted with anti-NMS produced a clear beta 3 I globulin line,
while no beta 3I globulin line was produced by NMS reacting with the same antiserum.
(2) TMS gave longer and denser beta 2 III and beta 2 I lines than NMS. This is more
evident in the following figure.
B. NMS and TMS diluted 1: 5 were reacted with antiserum to tumour extracts. Note
that in diluted NMS the beta 2 III line has become faint, and the beta 2 I line is shorter
and less dense. On the other hand, diluted TMS had still sufficient amounts of these two
beta globulins to produce conspicuous precipitation arcs. This plate also showed increase
of some alpha globulins in the TMS, a finding which (although confirming the results of
agar gel electrophoresis of TMS) appeared with only half of the antisera used.
FIG. 3. A. Immunoelectrophoretic analysis of tumour extracts. TL1 and TL2-first and
second extraction, respectively, oflyophilized tumour tissue. TF-extract of fresh tumour.
B. Ouchterlony plate, demonstrating absorption of antibodies to serum antigens from
anti-tumour serum. Centre well: anti-tumour serum absorbed with mouse serum. Top
and left wells: preparations of tumour extracts. Right well: normal mouse serum.
Note that the tumour extracts produced at least three precipitation arcs with the absorbed
antiserum. Mouse serum produced none.
FIGs. 5-7. Purification and identification of beta 2I and beta 2 III globulins.
Fig. 5.-A. Immunoelectrophoresis of the beta 2 globulin fraction as compared to serum
and tumourextract,reacting with antiserum to tumour. B. Immunoelectrophoresis ofserum
and tumour extract reacting with the beta 2 globulin immune serum.
Fig. 6. The indication of haemoglobin binding capacity of beta 2 III globulin. This
figure is a photomontage showing the analysis of tumour extract and the beta 2 fraction
with anti-tumour serum before and after benzidine staining. A-B. Tumour extract before (A)
and after (B) the benzidine reaction. C-D. beta 2 globulin fraction before (D) and after (c)
benzidine reaction. Note in both cases thepresence of a benzidine positive line correspond-
ing with the beta 2 III globulin line.
Fig. 7.-The identification of beta 2 I globulin as transferrin.
FIGs. 8-9. Immunoelectrophoretic analysis of mouse urines.
Fig. 8. Analysis of the constituents present in mouse urine as compared to serum.
A. Utilization of antisera to urine. Photo of the plate. B. Schematic drawing of the
immunoelectrophoretic patterns of normal mouse urine reaction with unabsorbed immune
serum to urine (below) and absorbed with mouse serum (above). c. Reaction of mouse urine
with immune serum to mouse serum. Note in this case that the only line appearing when
urine reacted with antiserum to mouse serum, occurs faintly in the albumin region. It
is not readily visible in the photographic reproduction.
FIG. 9.-A comparative analysis of antibodies present in antisera to urines of normal and
tumour-bearing mice, using mouse sera as the antigens. Note that while antisera to
normal mouse urine contains 2-3 precipitins against mouse sera, antisera to urine from
tumour-bearing mice shows a number of additional precipitin lines, whose intensity is
greater in the tumour serum.
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1 volume tumour exudate or
1 volume serum from tumour-bearing mice.
3 volumes Rivanol 0-4 per cent-overnight at 4° C.
Centrifugation 3000 r.p.m. for 10 minutes.
Precipitate
(discarded)
Supernatant
1 volume 0* 2M ZnSO4. pH 6*8-7*0
(after addition of ZnSO4).
Centrifugation 3000 r.p.m. for 10 minutes.
Precipitate
(discarded)
Supernatant
ft 2 I, f 2 III
FIG. 4.-Scheme of the procedure for the purification of beta 2 I and beta 2 III globulins.
3 II globulin-is present). The reaction of this antiserum with the beta 2
globulin fraction resulted in the appearance of a single precipitation line cor-
responding to the transferrin line (beta 2 I) of NMS.
III. Urinary Proteins of Normal and Tumour-bearing Mice
The urine contained a mixture of proteins, some of which were antigenically
identical with those of mouse serum, and others were antigenically distinct
from those of serum. This is illustrated in the following electrophoretic analyses.
When NMU was tested with the corresponding antiserum five to seven pre-
cipitation bands were evident (Fig. 8A, B). These may be described by their
migration in relation to the equivalent migration of serum proteins. There is
a large zone of protein extending from the prealbumin zone to the alpha 2 region
(Rho-Alpha 2), albumin, three alpha 2 globulins, one precipitation line produced
by a beta 1 globulin and one formed by a beta 2 globulin (Fig. 8A, B). When the
urine antiserum was absorbed with normal mouse serum, two lines-those of
albumin and of an alpha 2 globulin-disappeared. Five proteins, namely the
Rho-Alpha 2, two alpha 2 globulins, one beta 1 and one beta 2 globulin were
therefore indicated to be " urinary specific " proteins. Conversely, when urinary
proteins were analysed with anti-NMS serum, an albumin line (Fig. 8c) and two
lines with somewhat lesser migration (whose appearance was inconstant) were
formed. Esterase activity was found in one of the alpha 2 lines and in agar gel
electrophoresis also in the beta region. It would seem that the proteins in this
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region are in such low amounts or are of such low antigenicity that esterase
activity is not demonstrable in a precipitation line.
Urines from tumour-bearing animals show a similar pattern of " urinary
specific" protein distribution to that excreted by normal animals. However,
there appeared to be increased amounts and types of antigens immunologically
identical with serum proteins. When antisera against pathological urines reacted
with serum proteins, the presence of antibodies against many protein constituents
of serum was shown, whereas antisera to normal urine contained precipitating
antibodies only against albumin and the alpha 2 globulin described above (Fig. 9).
DISCUSSION
In the present study it was found that sera of cancerous animals contained
higher than normal amounts of lipoproteins with alpha globulin mobility (in
agar gel), haemoglobin binding beta 2 III globulin, beta 3 I globulin and trans-
ferrin. These results are in accordance with those obtained by other workers
who dealt with sera of cancer patients and tumour-bearing animals (Clausen
et al., 1959, 1960; Rask-Nielsen, Gormsen and Clausen, 1959; Rabinovich de
Piroski and Oisgold, 1962; Robert, Serpicelli and Jayle, 1956; Nyman,
1959; de Vaux St. Cyr, Cleve and Grabar, 1960). The significance of these
findings in relation to the cancer process is still obscure.
The immunoelectrophoretic study oftumour extracts revealed that an esterase
with a beta-gamma globulin mobility and some other proteins with similar
mobility may be tissular components. However, the other proteins in tumour
extracts, demonstrated by immunoelectrophoresis were either serum proteins or
possibly tumour tissue proteins possessing common antigenic determinants with
serum proteins.
The " urinary specific " antigens may represent either specific protein products
ofthe kidney orthe urinary tract (Boyce, King andFielden, 1961) or, alternatively,
split products of serum proteins as the result of metabolic activities of urinary
tract cells. de Vaux St. Cyr, Hermann and Talal (1962, 1963) and Hermann
(1963), working on human urine, have shown that it contained, in addition to
various serum constituents and degraded gamma globulins, some fractions which
were not demonstrable in serum, e.g. esterases and " uromucoide ".
The possibility that these types of protein may be secretions of the urinary
tract has not as yet been excluded. The second possibility that split products
with different antigenic sites may be obtained from one protein is supported by
the work of Burtin (1961) on gamma globulin.
The difference in antigen patterns in urine from normal animals and from
those bearing tumours is characterized by an increased number of serum antigens
in the latter. These serum proteins could be demonstrated when the antiserum
against TMUwas tested against normalserunm or serum oftumour-bearing animals.
The latter showed more lines against anti-TMU than did normal serum.
These antigens could also be revealed by use of tumour extracts reacting with
anti-TMU serum. When, however, this antiserum was absorbed with normal
serum, no precipitation bands were formed. We could thus confirm our previous
observation (Pikovski and Witz, 1961b) on the presence ofcertain tumour antigens
in urine of tumour-bearing mice. These proteins are part of the group of tumour
antigens possessing common antigenic sites with serum proteins, but might also
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be cell constituents. This point may be of special interest, bearing in mind
the similarity in the effect on tumour cells produced by immune sera to tumour
extracts and to urine of tumour-bearing mice (Pikovski, Witz and Tenenbaum,
1963).
The presence of serum proteins in TMA would suggest that if the kidney
clearance of proteins into the urine remained constant, then in the tumour-
bearing animal the increase of certain serum proteins (see above) would manifest
itself in the amounts of these proteins present in the urine. However, an addi-
tional factor seems to be operating, since even those protein fractions that are not
increased in the blood of tumour-bearing animals are present in the urine. This
would indicate that perhaps in the tumour-bearing animal the kidney clearance
of serum protein is somewhat elevated.
SUMMARY
Growth of mammary carcinoma in mice was shown to be associated with
increased concentrations of beta 2 I globulin (transferrin), beta 2 III globulin
(a haemoglobin binding protein) and beta 3 I globulin (constituent ofthe comple-
ment) in serum.
Soluble extracts of tumour contained marked concentrations of the beta 2 I
and the beta 2 III globulins. Three proteins with beta-gamma mobilities were
detected and in addition esterase activity was demonstrable in the beta 2 region
of the electropherogram. Neither the 3 latter proteins nor the esterase were
demonstrable in serum.
The transferrin and the haemoglobin binding beta 2 III globulin were partially
purified.
Normal mouse urine contained at least 5 to 7 proteins of which only two
albumin and an alpha globulin were identical with the corresponding serum
proteins. Urine from tumour-bearing mice showed additional proteins, immuno-
logically identical with those of serum and tumour extracts.
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